We have been growing twice as fast as the market. We have important products to offer to the Indian healthcare system. We are catching up to some degree in India, says Stefan Oschmann.
first published: Jan 24, 2014 12:56 pm
A collection of the most-viewed Moneycontrol videos.
Can Nifty Claw Back Above 25,600 Or Will Sensex Expiry Cap The Upside?| Opening Bell Live
Gold ETFs vs Silver ETFs | Which One Is Your Wealth Buddy?
Nifty Sees Triple-Digit Cut Despite Strong Q2 From SBI & M&M; All Sectors In Red | Closing Bell Live
Groww's Rs 6,632 Cr IPO Opens For Subscription | Management On Future Path | IPO Watch Live
